Asthma Clinical Trial
Official title:
The Use of Osteopathic Manipulation in a Clinic and Home Setting to Address Pulmonary Distress as Related to Asthma in Southwest Virginia
| NCT number | NCT00545376 |
| Other study ID # | F-12 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | October 2007 |
| Est. completion date | February 2008 |
| Verified date | July 2019 |
| Source | Edward Via Virginia College of Osteopathic Medicine |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
There is a high prevalence of asthma in southwest Virginia and there are multiple osteopathic
manipulative techniques (OMT) which are thought to improve lung function. However, there are
inadequate studies regarding the effectiveness of using osteopathic manipulative treatment
(OMT) as an office treatment or a home treatment to address obstructive lung disease. In
addition, there is little information on the level of acceptance, use, and cost effectiveness
of using OMT in rural southwest Virginia. The purpose of this study is to determine the
viability of OMT treatment with asthma, the level of acceptance in selected clinics in
southwest Virginia, and the effectiveness of home OMT education in order to implement a
program to improve asthma control. The study hypotheses are: 1. Osteopathic manipulation
delivered to the asthmatic patient will significantly improve spirometry values, thoracic
excursion, and subjective asthma symptoms. (.05 alpha) 2.Patients who are taught and use a
home treatment regime for asthma will significantly improve spirometry values, thoracic
excursion, and subjective asthma symptoms after two weeks, compare with those who do not have
home treatment.
3.Physicians educated on the use of OMT for asthma will increase their perceived future use
of OMT as an adjunct to treat this disorder.
| Status | Completed |
| Enrollment | 32 |
| Est. completion date | February 2008 |
| Est. primary completion date | January 2008 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 5 Years to 55 Years |
| Eligibility |
Inclusion Criteria: - Age 5-55 - mild intermittent, mild persistent, or moderate persistent asthma Exclusion Criteria: - severe persistent asthma - congestive heart failure - active pulmonary infection - oral steroid burst in past month - hospitalization for pulmonary causes in past three months - OMT treatment directed towards thoracic and ribs in past three months |
| Country | Name | City | State |
|---|---|---|---|
| United States | VCOM | Blacksburg | Virginia |
| Lead Sponsor | Collaborator |
|---|---|
| Edward Via Virginia College of Osteopathic Medicine |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Mini-AQLQ | 2 weeks | ||
| Primary | patient symptoms | pre and post OMT and follow-up | ||
| Primary | thoracic excursion | pre and post OMT and follow up | ||
| Primary | spirometry | pre and post OMT and follow up | ||
| Secondary | physician acceptance survey | pre and post study |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|